MC1953A1 - Derives de la benzopyrane - Google Patents
Derives de la benzopyraneInfo
- Publication number
- MC1953A1 MC1953A1 MC881987A MC1987A MC1953A1 MC 1953 A1 MC1953 A1 MC 1953A1 MC 881987 A MC881987 A MC 881987A MC 1987 A MC1987 A MC 1987A MC 1953 A1 MC1953 A1 MC 1953A1
- Authority
- MC
- Monaco
- Prior art keywords
- benzopyrane derivatives
- benzopyrane
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878715839A GB8715839D0 (en) | 1987-07-06 | 1987-07-06 | Benzopyran derivatives |
| GB888810212A GB8810212D0 (en) | 1987-07-06 | 1988-04-29 | Benzopyran derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1953A1 true MC1953A1 (fr) | 1989-06-30 |
Family
ID=26292440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC881987A MC1953A1 (fr) | 1987-07-06 | 1988-07-04 | Derives de la benzopyrane |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US4971982A (fr) |
| EP (1) | EP0298452B1 (fr) |
| JP (1) | JP2683581B2 (fr) |
| CN (1) | CN1023404C (fr) |
| AR (1) | AR245710A1 (fr) |
| AT (1) | ATE91127T1 (fr) |
| AU (1) | AU613646B2 (fr) |
| CA (1) | CA1334094C (fr) |
| CZ (1) | CZ285970B6 (fr) |
| DE (1) | DE3882095D1 (fr) |
| DK (1) | DK370988A (fr) |
| DZ (1) | DZ1227A1 (fr) |
| ES (1) | ES2056859T3 (fr) |
| FI (1) | FI90079C (fr) |
| HU (2) | HU202513B (fr) |
| IE (1) | IE62258B1 (fr) |
| IL (1) | IL86923A (fr) |
| IS (1) | IS1596B (fr) |
| MC (1) | MC1953A1 (fr) |
| MX (1) | MX174083B (fr) |
| NO (1) | NO170727C (fr) |
| NZ (1) | NZ225163A (fr) |
| PH (1) | PH27153A (fr) |
| PT (1) | PT87913B (fr) |
| SK (1) | SK279037B6 (fr) |
| SU (1) | SU1757466A3 (fr) |
| YU (1) | YU46918B (fr) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5387587A (en) * | 1986-12-23 | 1995-02-07 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Chroman derivatives |
| US5284838A (en) * | 1987-06-23 | 1994-02-08 | Elf Sanofi | Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma |
| US4971982A (en) * | 1987-07-06 | 1990-11-20 | Hoffmann-La Roche Inc. | Benzopyran derivatives |
| AU628331B2 (en) * | 1988-05-06 | 1992-09-17 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Chroman derivatives |
| DE3918041A1 (de) * | 1989-06-02 | 1990-12-06 | Merck Patent Gmbh | Chromanderivate |
| DE3922392A1 (de) * | 1989-07-07 | 1991-01-17 | Merck Patent Gmbh | Chromanderivate |
| DE3924417A1 (de) * | 1989-07-24 | 1991-01-31 | Merck Patent Gmbh | Chromanderivate |
| DE3926001A1 (de) * | 1989-08-05 | 1991-02-07 | Merck Patent Gmbh | Chromanderivate |
| US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| US5616610A (en) * | 1989-12-22 | 1997-04-01 | Astra Aktiebolag | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
| CN1060467A (zh) | 1990-09-25 | 1992-04-22 | 武田药品工业株式会社 | 1，3-苯并嗪衍生物、其生产方法和用途 |
| CA2061179A1 (fr) * | 1991-02-18 | 1992-08-19 | Ryuji Tsuzuki | Composes de type oxazinobenzazole |
| DE4115465A1 (de) * | 1991-05-11 | 1992-11-12 | Beiersdorf Ag | Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
| KR950009863B1 (ko) * | 1991-05-22 | 1995-08-29 | 재단법인한국화학연구소 | 벤조피란 유도체와 그의 제조방법 |
| FR2698873B1 (fr) | 1992-12-07 | 1995-02-24 | Lipha | Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant. |
| CA2142471A1 (fr) * | 1992-08-17 | 1994-03-03 | Hiroshi Koga | Derives de benzopyrane et de benzoxazine |
| ES2064228B1 (es) * | 1992-10-19 | 1995-09-01 | Uriach & Cia Sa J | Nuevas tetralonas con actividad farmacologica, composiciones que las contienen y procedimiento para su preparacion. |
| US5416097A (en) * | 1993-05-19 | 1995-05-16 | Berlex Laboratories, Inc. | Potassium channel activators/openers |
| US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
| CA2153498A1 (fr) * | 1993-11-10 | 1995-05-18 | Hidetsura Cho | Derive de chromanne et utilisation therapeutique de ce dernier |
| KR100254106B1 (ko) * | 1994-06-09 | 2000-05-01 | 타이도 나오카타 | 4-퀴놀리논 유도체 또는 그의 염 |
| US5470861A (en) | 1994-08-04 | 1995-11-28 | Hoffmann-La Roche Inc. | Method of promoting hair growth |
| US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
| US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
| US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| KR100691511B1 (ko) * | 1995-11-09 | 2007-04-19 | 다우 아그로사이언시즈 엘엘씨 | 크로만카복실레이트의제조방법 |
| JP3885900B2 (ja) * | 1996-03-22 | 2007-02-28 | 大日本インキ化学工業株式会社 | ベンゾピラン誘導体及びそれを有効成分とする心臓疾患治療剤 |
| WO1999001453A1 (fr) * | 1997-07-02 | 1999-01-14 | F. Hoffmann-La Roche Ag | Procede de fabrication de derives de chromanylpyridine a activite optique |
| EP1087963B1 (fr) | 1998-06-19 | 2004-08-25 | Chiron Corporation | Inhibiteurs de glycogene synthase kinase 3 |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
| FI20010233A0 (fi) * | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
| AR035087A1 (es) * | 2001-08-09 | 2004-04-14 | Syngenta Participations Ag | Piridil-alquinos y piridil-n-oxido-alquinos herbicidas activos, procedimiento para su preparacion, composicion herbicida y para inhibir el crecimiento de plantas, metodo para el control del crecimiento de plantas indeseables , y metodo para la inhibicion del crecimiento de plantas |
| AR040413A1 (es) * | 2002-05-31 | 2005-04-06 | Syngenta Participations Ag | Heterociclilalquinos activos como herbicidas |
| EP1937669B9 (fr) * | 2005-09-01 | 2012-07-18 | Janssen Pharmaceutica NV | Nouveaux dérivés de benzopyrane tels que des ouvreurs de canal de potassium |
| AU2006284860A1 (en) * | 2005-09-01 | 2007-03-08 | Janssen Pharmaceutica N.V. | Benzopyran and pyranopyridine derivatives as potassium channel openers |
| WO2008072801A1 (fr) * | 2006-12-13 | 2008-06-19 | Seoul National University Industry Foundation | Composés incluant un motif benzopyrane pour structures de noyau, et méthode de préparation des composés |
| CN103819395B (zh) * | 2014-02-24 | 2016-05-25 | 蚌埠中实化学技术有限公司 | 一种制备2-碘-5-苯基吡啶的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1583811A (en) * | 1977-05-09 | 1981-02-04 | Laroche Navarron Sa | Chromene derivatives |
| US4563468A (en) * | 1979-09-13 | 1986-01-07 | Burroughs Wellcome Co. | Chemotherapeutic agents |
| HU184359B (en) * | 1980-12-16 | 1984-08-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing substituted acyl-carbamides |
| US4443459A (en) * | 1981-05-26 | 1984-04-17 | Banyu Pharmaceutical Co., Ltd. | α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it |
| ATE23718T1 (de) * | 1981-09-25 | 1986-12-15 | Beecham Group Plc | Benzopyran-verbindungen mit pharmazeutischer wirkung. |
| DE3364734D1 (en) * | 1982-10-19 | 1986-08-28 | Beecham Group Plc | Novel chromans and chromenes |
| EP0172352B1 (fr) * | 1984-06-22 | 1990-08-29 | Beecham Group Plc | Composés benzopyranniques actifs |
| DE3669317D1 (de) * | 1985-09-11 | 1990-04-12 | Beecham Group Plc | Chromanderivate und aehnliche verbindungen mit blutdrucksenkender wirkung. |
| PT84806B (pt) * | 1986-05-03 | 1989-12-29 | Beecham Group Plc | Processo para a preparacao de benzopiranos |
| FI90343C (fi) * | 1987-06-23 | 1994-01-25 | Merck Patent Gmbh | Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi |
| US4971982A (en) * | 1987-07-06 | 1990-11-20 | Hoffmann-La Roche Inc. | Benzopyran derivatives |
-
1988
- 1988-06-23 US US07/210,692 patent/US4971982A/en not_active Expired - Fee Related
- 1988-06-24 NZ NZ225163A patent/NZ225163A/en unknown
- 1988-06-30 IL IL8692388A patent/IL86923A/en not_active IP Right Cessation
- 1988-06-30 AU AU18556/88A patent/AU613646B2/en not_active Ceased
- 1988-07-03 DZ DZ880098A patent/DZ1227A1/fr active
- 1988-07-04 HU HU883471A patent/HU202513B/hu not_active IP Right Cessation
- 1988-07-04 SK SK4841-88A patent/SK279037B6/sk unknown
- 1988-07-04 CZ CS884841A patent/CZ285970B6/cs not_active IP Right Cessation
- 1988-07-04 MC MC881987A patent/MC1953A1/fr unknown
- 1988-07-04 AR AR88311317A patent/AR245710A1/es active
- 1988-07-04 DK DK370988A patent/DK370988A/da not_active Application Discontinuation
- 1988-07-05 PT PT87913A patent/PT87913B/pt not_active IP Right Cessation
- 1988-07-05 IS IS3369A patent/IS1596B/is unknown
- 1988-07-05 YU YU130288A patent/YU46918B/sh unknown
- 1988-07-05 JP JP63166068A patent/JP2683581B2/ja not_active Expired - Lifetime
- 1988-07-05 SU SU884356220A patent/SU1757466A3/ru active
- 1988-07-05 CA CA000571115A patent/CA1334094C/fr not_active Expired - Fee Related
- 1988-07-05 CN CN88104200A patent/CN1023404C/zh not_active Expired - Fee Related
- 1988-07-05 NO NO883007A patent/NO170727C/no not_active IP Right Cessation
- 1988-07-05 IE IE204388A patent/IE62258B1/en not_active IP Right Cessation
- 1988-07-05 MX MX1216888A patent/MX174083B/es unknown
- 1988-07-06 DE DE8888110789T patent/DE3882095D1/de not_active Expired - Fee Related
- 1988-07-06 AT AT88110789T patent/ATE91127T1/de not_active IP Right Cessation
- 1988-07-06 EP EP88110789A patent/EP0298452B1/fr not_active Expired - Lifetime
- 1988-07-06 ES ES88110789T patent/ES2056859T3/es not_active Expired - Lifetime
- 1988-07-06 FI FI883232A patent/FI90079C/fi not_active IP Right Cessation
- 1988-07-06 PH PH37176A patent/PH27153A/en unknown
-
1990
- 1990-09-11 US US07/580,881 patent/US5118694A/en not_active Expired - Fee Related
-
1995
- 1995-06-19 HU HU95P/P00257P patent/HU211870A9/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MC1953A1 (fr) | Derives de la benzopyrane | |
| MC1992A1 (fr) | Derives de fluorocytidine | |
| TR26815A (tr) | Azolilmetil-sikropil türevleri | |
| DE3856154D1 (de) | Adenosin-Derivate | |
| MC1879A1 (fr) | Derives de la pyridazodiazepine | |
| TR24894A (tr) | N-FENILPIRAZOL TüREVLERI | |
| DK507188A (da) | Cholecalciferolderivater | |
| FR2639044B1 (fr) | Derives de la butynylamine | |
| DK378088A (da) | Alkenderivater | |
| DK223588A (da) | Benzazepinderivater | |
| MC1916A1 (fr) | Derives de propiolophenone | |
| DK110088A (da) | Chromonderivater | |
| MC1984A1 (fr) | Derives de la purine | |
| BR8905292A (pt) | Derivados de piranobenzoxadiazois | |
| MC1934A1 (fr) | Derives de pyrimidine | |
| DK453788D0 (da) | Rifamycinderivater | |
| DK271088A (da) | Tienopyridinderivater | |
| MC2108A1 (fr) | Derives de quinoleine | |
| DK695788A (da) | Naphtalenderivater | |
| FR2595704B1 (fr) | Derives de la proline | |
| DK733688D0 (da) | Dioxazocinderivater | |
| DK71488D0 (da) | Dipenylethylen-derivater | |
| DK46288A (da) | Pilocarpinderivater | |
| KR890003365U (ko) | 패용 표찰 | |
| FR2629901B1 (fr) | Antiretour de fumee |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |